Position in KURA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,654,118
-$7,435,054 QoQ
Shares Held
1,433,471
-22.0% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.94558662156402.ToString("F0")%
Shared 0.ToString("F0")%
None 0.05441337843597813.ToString("F0")%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Derivatives in KURA
reported options exposure · as of Dec 31, 2020CallValue
$2,286,200
CallShares
70,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. KURA ranks #131 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in KURA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,654,118 | 1,433,471 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,089,172 | 1,837,264 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $23,140,324 | 2,614,726 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,387,275 | 933,670 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,469,954 | 828,781 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $7,517,469 | 863,085 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,863,316 | 709,484 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,128,511 | 831,885 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $16,762,734 | 785,876 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,643,861 | 531,562 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,202,467 | 460,797 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $9,843,186 | 930,358 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $13,291,563 | 1,086,800 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $14,240,362 | 1,147,491 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $19,612,917 | 1,435,792 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $17,688,926 | 965,026 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $7,737,534 | 481,190 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,287,878 | 306,277 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,276,559 | 281,717 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,551,651 | 170,343 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $29,514,105 | 1,044,008 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $40,997,999 | 1,255,297 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $2,286,200 | 70,000 | Call | Defined | 2021-02-12 | |
| 2020-09-30 | $18,515,629 | 604,296 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,296,905 | 631,712 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $959,587 | 96,441 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||